Facilitating collaborations to develop combination investigational cancer therapies workshop summary

"Advances in biomedical research have increased our understanding of the complex nature of disease and the interaction of multiple molecular pathways involved in cancer. Combining investigational products early in their development is thought to be a promising strategy for identifying effective...

Descripción completa

Detalles Bibliográficos
Autor principal: Institute of Medicine (U.S.) (-)
Autores Corporativos: National Cancer Policy Forum (U.S.), Institute of Medicine (U.S.). Board on Health Care Services
Otros Autores: Patlak, Margie (-), Balogh, Erin, Nass, Sharyl J.
Formato: Libro electrónico
Idioma:Inglés
Publicado: Washington, D.C. : National Academies Press 2012.
Edición:1st ed
Materias:
Ver en Biblioteca Universitat Ramon Llull:https://discovery.url.edu/permalink/34CSUC_URL/1im36ta/alma991009622257406719
Tabla de Contenidos:
  • Introduction
  • Why Combinations and Collaborations Are Necessary
  • Scientific Challenges in Developing Investigational Combination Therapies
  • Overcoming Cultural Challenges to Collaborations Legal Issues in Collaborations
  • Financial Challenges
  • Regulatory Issues
  • Codevelopment of Therapies for HIV as a Model
  • Examples of Collaborations Relevant to Cancer
  • Wrapping Up
  • Appendix A: Examples of Collaborations
  • Appendix B: Workshop Agenda
  • References
  • Acronyms.